ERCC1 and neoplasm: In addition, Fareed et al. reported that CDDP-based preoperative chemotherapy for gastroesophageal adenocarcinoma had significantly better pathologic tumor reduction and survival in ERCC1-negative tumors diagnosed using immunohistochemistry, which can be used as a predictive marker for treatment [20].